Total Payments
$29,093
2024 Payments
$379.00
Companies
47
Transactions
393
Medicare Patients
2,496
Medicare Billing
$396,725
Payment Breakdown by Category
Consulting$18,294 (62.9%)
Food & Beverage$7,307 (25.1%)
Other$1,862 (6.4%)
Travel$1,287 (4.4%)
Education$341.88 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,294 | 8 | 62.9% |
| Food and Beverage | $7,307 | 365 | 25.1% |
| Honoraria | $1,613 | 2 | 5.5% |
| Travel and Lodging | $1,287 | 6 | 4.4% |
| Education | $341.88 | 11 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12,502 | 25 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $4,103 | 6 | $0 (2024) |
| Celgene Corporation | $2,138 | 18 | $0 (2020) |
| TG THERAPEUTICS, INC. | $1,665 | 1 | $0 (2021) |
| Rigel Pharmaceuticals, Inc. | $1,632 | 6 | $0 (2022) |
| Janssen Biotech, Inc. | $774.20 | 28 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $613.38 | 13 | $0 (2022) |
| Amgen Inc. | $526.86 | 25 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $440.31 | 28 | $0 (2021) |
| GENZYME CORPORATION | $356.54 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $379.00 | 2 | TerSera Therapeutics LLC ($229.00) |
| 2023 | $277.49 | 4 | AstraZeneca Pharmaceuticals LP ($135.00) |
| 2022 | $1,822 | 3 | Rigel Pharmaceuticals, Inc. ($1,572) |
| 2021 | $1,683 | 2 | TG THERAPEUTICS, INC. ($1,665) |
| 2020 | $6,657 | 60 | Janssen Scientific Affairs, LLC ($3,953) |
| 2019 | $12,302 | 111 | Novartis Pharmaceuticals Corporation ($10,300) |
| 2018 | $1,920 | 102 | Takeda Pharmaceuticals U.S.A., Inc. ($207.81) |
| 2017 | $4,051 | 109 | Novartis Pharmaceuticals Corporation ($2,078) |
All Payment Transactions
393 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | TerSera Therapeutics LLC | — | Consulting Fee | Cash or cash equivalent | $229.00 | General |
| 09/05/2024 | Janssen Scientific Affairs, LLC | TALVEY (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: Oncology | ||||||
| 12/11/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $92.02 | General |
| Category: Hematology | ||||||
| 12/08/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 07/13/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: CELLT | ||||||
| 05/22/2023 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $28.50 | General |
| 12/09/2022 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug) | Food and Beverage | In-kind items and services | $109.43 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 05/12/2022 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Honoraria | Cash or cash equivalent | $1,462.50 | General |
| Category: Hematology | ||||||
| 03/09/2022 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| 09/23/2021 | TG THERAPEUTICS, INC. | UKONIQ (Drug) | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| Category: Hematology | ||||||
| 05/14/2021 | E.R. Squibb & Sons, L.L.C. | — | Education | In-kind items and services | $18.18 | General |
| 11/25/2020 | Secura Bio, Inc. | Farydak (Drug) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Oral Oncologic | ||||||
| 11/06/2020 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Oncology | ||||||
| 10/29/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/28/2020 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: Oncology | ||||||
| 10/08/2020 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA, POLIVY | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: BioOncology | ||||||
| 10/06/2020 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2020 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2020 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Hematology | ||||||
| 09/03/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Oncology | ||||||
| 09/02/2020 | Merck Sharp & Dohme Corporation | PREVYMIS (Drug), DIFICID, ZINPLAVA | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/20/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/18/2020 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Oncology | ||||||
| 08/13/2020 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: BioOncology | ||||||
| 08/12/2020 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 429 | 622 | $138,234 | $40,163 |
| 2022 | 8 | 519 | 894 | $171,240 | $58,995 |
| 2021 | 10 | 530 | 872 | $152,244 | $63,431 |
| 2020 | 23 | 1,018 | 51,927 | $1.1M | $234,136 |
Total Patients
2,496
Total Services
54,315
Medicare Billing
$396,725
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 122 | 234 | $55,234 | $16,740 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 163 | 190 | $26,507 | $8,944 | 33.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 53 | 58 | $19,065 | $3,814 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 30 | $10,468 | $3,446 | 32.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 55 | $11,253 | $3,303 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 37 | 37 | $8,797 | $2,216 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $6,910 | $1,700 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 126 | 233 | $47,200 | $16,684 | 35.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 211 | $37,614 | $11,833 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 34 | 92 | $24,020 | $10,365 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 169 | 201 | $25,768 | $9,284 | 36.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 80 | 88 | $24,674 | $6,959 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 27 | 27 | $5,092 | $1,541 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $4,464 | $1,519 | 34.0% |
| 99451 | Telephone or internet assessment with written report by consulting physician, 5 minutes or more | Facility | 2022 | 23 | 28 | $2,408 | $811.39 | 33.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 140 | 234 | $36,743 | $17,876 | 48.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 30 | 124 | $28,676 | $14,585 | 50.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 171 | $28,360 | $10,041 | 35.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 149 | 160 | $15,825 | $8,066 | 51.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 77 | 81 | $21,234 | $6,568 | 30.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 24 | 24 | $6,677 | $2,554 | 38.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 33 | 33 | $5,271 | $2,037 | 38.6% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2021 | 21 | 21 | $8,819 | $1,462 | 16.6% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2021 | 12 | 12 | $324.00 | $123.36 | 38.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 12 | 12 | $315.00 | $120.00 | 38.1% |
About Dr. Scott Hall, MD
Dr. Scott Hall, MD is a Hematology healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013913292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Hall, MD has received a total of $29,093 in payments from pharmaceutical and medical device companies, with $379.00 received in 2024. These payments were reported across 393 transactions from 47 companies. The most common payment nature is "Consulting Fee" ($18,294).
As a Medicare-enrolled provider, Hall has provided services to 2,496 Medicare beneficiaries, totaling 54,315 services with total Medicare billing of $396,725. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Newark, DE
- Active Since 06/22/2005
- Last Updated 03/07/2011
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1013913292
Products in Payments
- TASIGNA (Drug) $11,023
- IMBRUVICA (Drug) $4,439
- UKONIQ (Drug) $1,665
- Tavalisse (Drug) $1,522
- Revlimid (Drug) $337.80
- DARZALEX (Biological) $287.76
- CALQUENCE (Drug) $236.67
- Imbruvica (Drug) $218.67
- Copiktra (Drug) $218.39
- XARELTO (Drug) $208.68
- EMPLICITI (Biological) $190.48
- Kyprolis (Biological) $183.67
- NINLARO (Drug) $171.56
- ADCETRIS (Biological) $170.73
- CABLIVI (Biological) $166.00
- Blincyto (Biological) $161.69
- Nplate (Biological) $150.39
- Soliris (Drug) $150.00
- TALVEY (Biological) $150.00
- Venclexta (Drug) $134.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Newark
Dr. Michael Lankiewicz, Md, MD
Hematology — Payments: $4,793
Hematology $4,793
Dr. Robert Slease, Md, MD
Hematology — Payments: $1,602
Hematology $1,602
Dr. Shiyama Mudali, M.d, M.D
Hematology — Payments: $93.70
Hematology $93.70
Dr. Philip Blatt, Md, MD
Hematology
Hematology
Santos Martin, Md, MD
Hematology
Hematology